Researchers explore new anti-HIV agents.
Stephenson
Joan
J
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D065100:CCR5 Receptor Antagonists; D002986:Clinical Trials as Topic; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D015507:Drugs, Investigational / Q000494:pharmacology / Q000627:therapeutic use; D000077560:Enfuvirtide; D005663:Furans; D006678:HIV / Q000187:drug effects; D015699:HIV Envelope Protein gp120 / Q000187:drug effects; D015700:HIV Envelope Protein gp41 / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use; D006801:Humans; D009570:Nitriles; D010091:Oximes; D010446:Peptide Fragments / Q000627:therapeutic use; D010879:Piperazines; D010880:Piperidines; D011724:Pyridazines; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D014230:Triazoles
D019380:Anti-HIV Agents; C451732:BMS 806; D065100:CCR5 Receptor Antagonists; D003497:Cyclic N-Oxides; D015507:Drugs, Investigational; D005663:Furans; D015699:HIV Envelope Protein gp120; D015700:HIV Envelope Protein gp41; D019428:HIV Integrase Inhibitors; D009570:Nitriles; D010091:Oximes; D010446:Peptide Fragments; D010879:Piperazines; D010880:Piperidines; D011724:Pyridazines; D011725:Pyridines; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; C451733:S 1360; D014230:Triazoles; C451734:etravirine; D000077560:Enfuvirtide; C438583:Ancriviroc